Literature DB >> 18355914

Hypofractionation in radiotherapy for breast cancer.

Harry Bartelink1, Rodrigo Arriagada.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18355914     DOI： 10.1016/S0140-6736(08)60349-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Are Three Weeks of Whole-Breast Radiotherapy as Good as Five Weeks in Early Breast Cancer? - 10 Year Follow-Up in the Canadian Trial of Hypofractionated Radiation Therapy.

Authors: 
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

2.  Hypofractionated radiotherapy has the potential for second cancer reduction.

Authors:  Uwe Schneider; Jürgen Besserer; Andreas Mack
Journal:  Theor Biol Med Model       Date:  2010-02-11       Impact factor: 2.432

3.  Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors.

Authors:  Patrizia Ciammella; Ala Podgornii; Maria Galeandro; Renato Micera; Dafne Ramundo; Tamara Palmieri; Elisabetta Cagni; Cinzia Iotti
Journal:  Radiat Oncol       Date:  2014-04-24       Impact factor: 3.481

Review 4.  The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review.

Authors:  Gustavo Nader Marta; Charlotte Coles; Orit Kaidar-Person; Icro Meattini; Tarek Hijal; Yvonne Zissiadis; Jean-Philippe Pignol; Duvern Ramiah; Alice Y Ho; Skye Hung-Chun Cheng; Gemma Sancho; Birgitte Vrou Offersen; Philip Poortmans
Journal:  Crit Rev Oncol Hematol       Date:  2020-08-26       Impact factor: 6.312
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.